Type 2 diabetes mellitus · women with gestational diabetes mellitus
1 finding from 1 review
Perineal trauma · women with gestational diabetes mellitus
1 finding from 1 review
Postnatal depression · women with gestational diabetes mellitus
1 finding from 1 review
Postnatal weight retention or return to pre‐pregnancy weight · women with gestational diabetes mellitus
1 finding from 1 review
Perinatal mortality · women with gestational diabetes mellitus
1 finding from 1 review
Large‐for‐gestational age · women with gestational diabetes mellitus
It is very uncertain whether telemedicine changes large‐for‐gestational age compared with standard care (very low certainty).
1 finding from 1 review
Time to progression · women with hormone‐sensitive advanced breast cancer
Fulvestrant showed no clear difference in time to progression compared with other endocrine treatment (moderate certainty).
1 finding from 1 review
Clinical benefit rate · women with hormone‐sensitive advanced breast cancer
Fulvestrant showed no clear difference in clinical benefit rate compared with other endocrine treatment (high certainty).
1 finding from 1 review
All‐cause mortality · women with hormone‐sensitive advanced breast cancer
Fulvestrant showed no clear difference in mortality compared with other endocrine treatment (high certainty).
1 finding from 1 review
Vasomotor toxicity · women with hormone‐sensitive advanced breast cancer
Fulvestrant showed no clear difference in vasomotor toxicity compared with other endocrine treatment (high certainty).
1 finding from 1 review
Arthralgia · women with hormone‐sensitive advanced breast cancer
Fulvestrant showed no clear difference in arthralgia compared with other endocrine treatment (high certainty).
1 finding from 1 review
Gynaecological toxicity · women with hormone‐sensitive advanced breast cancer
Fulvestrant showed no clear difference in gynaecological toxicity compared with other endocrine treatment (high certainty).
1 finding from 1 review